natgillin/translations-raw huggingface dataset:
Opfattelserne i medlemsstaterne og de faktiske vilkår er for forskellige.
However, I take note of your remarks, and I think that we ought to take up the matter again with the group chairmen and in the Bureau.
Med hensyn til de udviklingslande, der er associeret med Fællesskabet, kan man udnytte mulighederne inden for rammerne af Lomé­aftalen.
Your committee and its rapporteur have attempted to rise above these controversies, which are often immoderate in tone and even sterile, and present a constructive, realistic assessment of the situation in this sector and its future.
Man vil især tale herom i forbindelse med Lomé III, som vi — som bekendt — skal forhandle om fra september i år.
1-979/82) by Mr Deleau, on behalf of the Committee on Economic and Monetary Affairs, on the production and use of pharmaceutical products in the Com munity.
Til slut henviser jeg endnu engang til det forsknings­og udviklingsprogram, som Rådet allerede har vedtaget på det videnskabelige og tekniske område, for at fremme udviklingen i perioden 1983­86.
Mr Deleau (DEP), rapporteur. — (FR) Madam President, Ladies, Gentlemen, the document that I have the honour to present ot you on behalf of the Committee on Economic and Monetary Affairs is a general report
Kommissionen opfordrer imidlertid Rådet til at beskæftige sig med hele problemstillingen, også på grundlag af den beslutning, som Parlamentet drøfter her.
Deleau developed along three main lines, discussed in the three main sections of the report, and I shall comment briefly on each of these in turn.
Desuden erkender Kommissionen, at det drejer sig om en teknisk meget vanskelig og også politisk ømtålelig sag.
We also stress the quality standards with which exports should comply.
Også dette program indeholder et delprogram under betegnelsen: lægeforsorg, sundhedsvæsen og ernæring i tropiske områder.
The second section deals with market conditions. In the marketing of its products, the pharmaceutical industry has a duty to observe the rules of competition, but at the same time it is entitled to expect the Community to create a genuinely open market in pharmaceutical products throughout its territory.
Innovation af produkter og metoder er hidtil stort set varetaget af den europæiske farmaceutiske industri på tilfredsstillende vis.
In view of the rising costs of research and the very keen international competition that it is facing, from the United States and Japan in particular, especially Japan which is developing rapidly in this field, it is clear that the European pharmaceutical industry, like other industries, must define its priorities and direct its research effort accordingly.
Vi betragter det imidlertid som vor opgave at sørge for en ringere belastning af virk­somhederne, især ved hjælp af toksikologiske under­søgelser.
It is for this reason that our report includes a paragraph calling upon the Community institutions to play a coordinating role in the field of pharmaceutical research, although without arrogating to themselves the responsibilities of private research laboratories.
Dette gør vi ikke mindst, fordi vi der igennem samtidig kan spare et alt for stort antal forsøgsdyr, og endvidere kan vi undgå, at alt for mange forsøgsdyr ofres.
We also call upon the Commission to conduct a review of the various national pharmaceutical research programmes to see whether they can be coordinated so as to avoid duplication and fill any gaps found.
Endvidere vil vi iagttage og undersøge lægemiddelindustriens fremtidige behov på specielle områder som for eksempel bioteknologi.
Our report also stresses the need for transparency of the market in pharmaceuticals, whether from the view point of parallel imports or from that of the fiscal sys tems in force.
Fællesskabets tredie forskningsprogram på det medicinske område og forsknings­ og udviklingspro­grammet inden for molekular­biologisk teknik er grundlaget for de specifikke aktioner på lægemiddel­området.
We do not wish to see pharmaceutical research and laboratories subjected to rigid regulations, since this would detract from the spirit of innovation and flexibility that private laboratories have consistenly shown hitherto.
Et punkt, der også blev stillet til debat i skriftlige forespørgsler, drejer sig om mindstenormer i forbin­delse med eksport.
Similarly, we call upon the Commission to investigate means of strengthening the legal protection of pharmaceutical inventions, the value of which is currently limited by the length of the test periods stipulated.
De høje kvalitetskrav, der er opnået ved hjælp af fællesskabsharmonisering, har haft gunstig virkning både i industrilandene og i udviklingslandene.
In return for accepting these obligations, the pharmaceutical industry should enjoy the benefits of access to the vast market offered by the Community, which it needs in order to remain competitive.
Udviklingslandene har fremover større sikkerhed for de medikamenter, der er frem­stillet i Fællesskabet; dette opnås også i samarbejde med Verdenssundhedsorganisationen.
To this end we urge the Council to adopt the proposal for a directive on the mutual recognition of marketing authorizations without further delay, this being an essential step in the progress towards free movement of goods.
Enhver frem­stilling af medikamenter kræver en tilladelse og kontrolleres til stadighed.
Deleau economy and, of course, in the paramount interests of the health of our fellow citizens.
Verdenssundhedsorganisati­onen har især for udviklingslande indført et kvalitets­certifikat som den kan forlange af hvert medlemsland i Verdenssundhedsorganisationen.
desirable, particularly in view of the fact that Com munity citizens are travelling more and more outside their countries of residence, visiting other Member States, where they may wish to obtain medicines.
De spørgsmål, der er behandlet i ændringsforslagene, kan opdeles i 3 grupper.
The first of these is the training of doctors, particularly in the fields of therapeutic techniques and drug control.
For det første ændrings­forslag om spørgsmål, der allerede blev berørt i forslaget til beslutning.
The second is education of consumers, by means of an information campaign on the correct use of pharmaceutical products in particular.
For det andet ændrings­forslag, der henviser til lægemiddelproblemer i udvik­lingslandene, og for det tredie ændringer og spørgsmål, der berører almene sundhedspolitiske aspekter.
The third is the exercise of controls over marketing techniques used to promote pharmaceuticals, by means in parti cular of regulations on advertising and publicity in this field and sanctions for any abusive practices.
Med hensyn til den første gruppe ændringsforslag kan jeg sige, at vi generelt har få problemer med dem.
It is for this reason that we have made sure to make the cost of drugs a central factor in our deliberations, on an equal footing with the quality and safety factors.
Ændringsforslagene drejer sig også om reklame for lægemidler i tredjelande. Reklame for lægemidler er allerede underkastet mere eller mindre strenge regler i de enkelte stater, hvis harmonisering for øjeblikket synes vanskelig ikke mindst af forfatningsredige grunde.
I trust, Ladies and Gentlemen, that you will also accept the conclusions set out in this report, in which we have endeavoured to be constructive and objective, both in the interests of this important sector of the
Alligevel vil "den officielle oversigt over produktegenskaber, der er foreslået af Kommissionen i 1980, kunne udgøre et referencegrundlag for oplys­ninger om lægemidler eller reklame for lægemidler i hele Fællesskabet, ι
Funds for research into sectors that have hitherto been neglected could be increased, for example, and Member States could be asked to orient the work of the public research institutions in that direction, so as to obtain more effective and at the same time less costly drugs, whilst avoiding imposing excessive restrictions on the research work of private enterprises or taking over their role. I had proposed an amendment relating to
I øvrigt har de farmaceutiske direktiver allerede harmoniseret emballagebilag og etikettering på fælles skabsplan, således at disse dokumenter også er til rådighed i tredjelande.
Finally, may I draw your attention to the research and development programme, already accepted by the Council, in the field of science and technology in the service of development for 1983-86.
Tredje kategori ændringsforslag — nemlig nr. 27 til 30 angår forlsag om, at Kommissionen skal gennem føre foranstaltninger inden for den almene sundhedspolitik og i det omfang disse forslag passer ind i rammerne af allerede eksisterende aktiviteter og er forenelige med Fællesskabets kompetence, kan de og vil de blive inddraget i overvejelserne.
The Community's third research programme in the field of medicine and the research and training pro gramme in the field of molecular biological techniques are of basic importance and involve work on specific pharmaceutical projects.
det således, som vi udtrykte det i udvalget — at standse uret i 4 uger; ikke for således som sidste år at udskyde eller nægte decharge, men for at træffe en endelig afgørelse i maj.
In future the develop ing countries will have more security as regards drugs manufactured in the Community, thanks also to the cooperation of the World Health Organization.
Vi har ganske enkelt brug for disse fire uger for at få en klar meningstilkendegivelse fra Kommissionen.
On the first group of amendments, I can say that in general we see few problems. In principle we can accept them all.
Decharge for 1981 — Europa-ParUmentet og EIB — Parhmentets driftsregnskab for 1982
Discharge decisions 1981 — European Parliament and European Investment Bank —Administrative expendi ture for 1982
Formanden. — Næste punkt på dagsordenen er forhandling under ét om seks betænkninger udarbejdet for budgetkontroludvalget:
President. — The next item is a joint debate on six reports drawn up on behalf of the Committee on Budgetary Control:
1-75/83) over Europa-Parlamentets regnskaber og decharge for regn skabsåret 1981;
1-75/83) on the accounts of the European Parliament and the discharge in respect of the 1981 financial year;
1-112/83) om decharge til Kommissionen for De europæiske Fællesskaber vedrørende den anden og tredje europæiske ud viklingsfonds virksomhed i regnskabsåret 1981;
1-112/83) on the discharge to be granted to the Commission in respect of the activities of the second and third "European Development Funds in the 1981 financial year; evaluate politically the implementation of the budget on the basis of the policies decided upon by Parlia ment, and the economic transparency and orderly execution of the financial operations, which here of course also includes compliance with the Financial Regulation and the internal procedural provisions.
— af Gabert (dok.
— by Mr Gabert, (Doc.
1-97/83) om decharge til Kommissionen for De europæiske Fællesskaber vedrørende EKSFs regnskaber for regnskabsåret 1981 og om Revisionsrettens beretning om Det europæiske Kul- og Stålfællesskabs finanser pr. 31. december 1981 og om Revisionsrettens beretning om EKSF- lån til boliger;
1-97/83) on the discharge to be granted to the Commission in respect of the financial statements of the ECSC for the 1981 financial year, and on the report of the Court of Auditors on the accounts of the European Coal and Steel Community as at 31 December 1981, and on the report of the Court of Auditors on ECSC housing loans;
1-70/83) om decharge til bestyrelsen for det europæiske institut til forbedring af leve- og arbejdsvilkårene for gennemførelsen af dets bevillinger for regnskabsåret 1981 og bemærkningerne til afgørelsen herom;
1-70/83) on the discharge to be granted to the Administrative Council of the European Foundation for the Improvement of Living and Working Conditions in respect of the implementation of its budget for the 1981 financial year and comments on this decision;
1-96/83) om decharge til bestyrelsen for det europæiske center for udvikling af erhvervsuddannelse for gennem førelsen af bevillingerne for regnskabsåret 1981 og bemærkningerne til denne afgørelse;
1-96/83) on the discharge to be granted to the Administrative Council of the European Centre for the Development of Vocational Training in respect of the implementation of its budget for the 1981 financial year and comments on this decision;
Jeg vil gerne komme med endnu en bemærkning.
May I make a second remark.
Er der sket en korrektion, har Parlamentet altså opnået det, som det ønskede; det behøver ikke nævne flere betingelser, det er tilstrækkeligt blot at konstatere, at der forelå en fejl, men at sagen i mellemtiden er gået ind i en positiv udvikling.
If the policy was corrected, Parliament has achieved what it wanted and does not need to impose any requirements, for then it is enough simply to establish that mismanagement occurred, but that a positive development has occurred since.
Omvendt gælder det naturligvis, for en fejl i 1981, som er forværret ved fortsættelse af en fejlagtig politik, at man naturligvis ligeledes må tage hensyn til Kommissionens fortsatte adfærd i forbindelse med bedømmelsen af spørgsmålet om decharge.
Conversely, in the case of mismanagement in 1981, reinforced by the continued pursuit of an improper policy, the Com mission's further conduct must also be taken into account in the evaluation of the discharge findings.
1-1309/82) om forbindelserne mellem Europa-Parlamentet og Den europæiske Investeringsbank og den parlamentariske kontrol af de budgetmæssige transaktioner i forbindelse med Den europæiske Investeringsbanks virk somhed.
1-1309/82) on relations between the European Parliament and the European Investment Bank and ways in which Parlia ment may supervise the budgetary operations associated with the activities of the European Investment Bank.
Sammenfattende vil jeg gerne sige, at vi i denne uge kun foreslår, at vi meddeler decharge for følgende betænkninger: 1.
In summary, may I say that this week we propose discharge decisions for the following reports only: 1.
EKSF, 2. instituttet i Berlin, 3. centret i Berlin, 4. den anden og tredie udviklingsfond, og som det sidste punkt den såkaldte Sabybetænkning, hvor der ganske vist ikke er nogen decharge, men hvori vi tager stilling til regnskabet for 1982 over for Kommissionen.
ECSC, 2. the Dublin Foundation, 3. the Berlin Centre, 4. the second and third development funds, and lastly the so-called Saby report where the question of discharge does not arise but in which we put our position vis-à-vis the Commission on the 1982 accounts.
Aigner budgetkontroludvalget.
Mr Aigner (EPP), Chairman of the Committee on Budgetary Control. — (DE) Mr President, as chair man of the Committee on Budgetary Control I would like to begin with a point of order.
En vurdering af, om det er fuldstændigt nye oplysninger eller blot gamle oplysninger i ny form, kan ingen foretage.
Your committee has decided — I may put it the way we put it in com mittee — to stop the clock for four weeks; not, like last year, to defer or refuse the discharge but in order to reach a final decision in May.
Det må udvalget vurdere, og derfor vil vi i næste uge behandle dette spørgsmål som første punkt.
We need these four weeks simply in order to obtain a clear expression of opinion from the Commission.
Formanden. — Hr. Aigner, jeg forstår, at De beder formanden om at anmode om, at betænkningen (dok.
President. — Mr Aigner, I gather that what you are asking the Chair to do is to put to the House the question of referring the report (Doc.
1-75/83) henvises til fornyet udvalgsbehandling.
1-75/83) to the committee.
Endnu en bemærkning til det, De sagde, hr. formand.
Debates of the European Parliament
Finansforordningen foreskriver nemlig frister, og vi må begrunde over for Kommissionen, hvorfor vi har brug for endnu fire uger, og denne forklaring giver vores hovedordfører nu på budgetkontroludvalgets vegne; først da kan vi henvise betænkningen til fornyet udvalgsbehandling.
83 deadlines, and we must justify ourselves before the Commission and explain why we need four more weeks; our rapporteur will make this statement now on behalf of the Committee on Budgetary Control, and only then can we refer the report back to com mittee.
Jeg beder om, at man nøjagtigt lægger mærke til det.
I ask you to take careful note of this.
Aigner (PPE), formand for budgetkontroludvalget. — (DE) Hr. formand, naturligvis, men det drejer sig også om fremsættelsen af en erklæring og udvalgets holdning, fordi vi ikke overholder finansforordningen.
Mr Aigner (EPP), Chairman of the Committee on Budgetary Control. — (DE) Mr President, of course I am, but it is also a question of formulating a statement and of the committee's position, since we are not observing the Financial Regulation.
Derfor sagde jeg, at vi skulle standse uret, men Kommissionen har ret til at erfare, hvorfor vi standser uret, og hvorfor vi først vil forelægge den endelige betænkning for Parlamentet i maj.
That is why I said that we are stopping the clock, but the Commission has a right to know why we are stopping the clock and why we are not presenting Parliament's final report until May.
Det er en an modning om fornyet udvalgsbehandling i henhold til artikel 85.
That is a recommendation for referral to committee under Rule 85.
Boserup (COM). — Jeg vil meget gerne vide, hvad der foregår her. Vi gjorde os i mandags megen umage med at få Saby-betænkningen behandlet separat.
Mrs Boserup (COM). — (DA) I should very much like to know what is happening here.
Står denne beslutning ved magt?
Is this decision valid?
Er der forslag om at fjerne Saby-betænkningen?
Is there a proposal to defer the Saby report?
Det er foreslået at fjerne Saby-betænkningen fra dagsordenen.
It has been proposed to take the Saby report off the agenda.
Dette vil jeg gerne tale imod.
I should like to oppose that.
Saby-betænkningen har intet som helst at gøre med decharge.
The Saby report has nothing whatever to do with discharge.
Det er et specielt spørgsmål, en pligt vi har, og den kan vi udføre helt uanset decharge.
It is a special question, a duty we have, and we can perform it regardless of discharge.
Irmer (L) — (DE) Hr. formand, før vi tager stilling til dette forslag fra hr. Aigner, vil jeg gerne bede Dem give en bindende erklæring om, at der rent faktisk er stillet nye oplysninger til rådighed.
Mr Irmer (L). — (DE) Mr President, before we give our opinion on Mr Aigner's proposal, I would ask you for a binding declaration that new information really has been made available.
Det overrasker mig noget, at budgetkontroludvalget for en eller to uger siden har erklæret, at man kunne foreslå Parlamentets decharge for 1981, og at der så en eller to dage før forhandlingen pludselig dukker nyt materiale op, der drager denne beslutning i tvivl.
I do find it rather suprising that the Committee on Budgetary Control determined one or two weeks ago that it could propose a discharge for Parliament for 1981 and that then, virtually a day or two before the debate, new material is suddenly supposed to have come to light which puts this decision in question again.
Jeg vil altså gerne bede Dem om at erklære bindende, at meddelelsen fra hr. Dankert til formanden for budgetkontroludvalget, hr. Aigner, rent faktisk indeholder nye oplysninger, der er væsentlige for afgørelsen af spørgsmålet, om der kan meddeles Parlamentet decharge eller ikke; iøvrigt vil jeg gerne udtrykke min forbavselse over, at disse oplysninger praktisk talt gives i sidste mimet.
So I would ask you to make a binding statement to the effect that President Dankert's communication to the chairman of the Committee on Budgetary Control, Mr Aigner, really does contain new information which is essential to the decision on this question of whether Parliament can be given a discharge or not; moreover, I would like to express my displeasure at the fact that this information is being given virtually at the last minute.
Aigner (PPE), formand for budgetkontroludvalget. — (DE) Jeg vil gerne forsøge at forklare Dem, hvad vi har vedtaget med stort flertal.
Mr Aigner (EPP), Chairman of the Committee on Budgetary Control. — (DE) I would like to try to make clear to you what we have decided by a large majority.
Vi ville i dag blot afgive den erklæring over for Kommissionen, som vi er forpligtet til, og såfremt Kommissionen tager stilling til det — hr. Tugendhat har sagt til mig, at han vil give sit svar — kan vi træffe afgørelse om tilbage visning eller ikke.
All we want to do today is to make the state ment to the Commission which we are obliged to make, and when the Commission expresses its position on it — Mr Tugendhat, the Vice-President, told me he will give an answer — then we can decide on with drawal or non-withdrawal.
Efter min opfattelse behøver vi slet ikke nogen afgørelse længere, fordi udvalget erklærer, at det først vil træffe endelig afgørelse på næste møde.
In my view we do not need a decision at all now, because the committee has stated that it will not take its final decision until the next partsession.
Anderledes forholder det sig med Sabybetænkningen, hvor vi ifølge finansforordningen er forpligtet til at forelægge regnskabet, således at Kommissionen kan arbejde videre, og det gør vi.
The Saby report is a different matter, for according to the Financial Regulation we are obliged to present the accounts so that the Commission can continue its activities, and we shall do so.
Men vores udtalelse herom kan vi ikke afgive nu, men først på næste møde.
But we can not give our opinion on it now, only at the next partsession.
Vi vil også først træffe endelig afgørelse om decharge for 1981, når vi har undersøgt de nye oplysninger, som hr. Dankert har forelagt.
Similarly, we will only reach a final decision on the discharge for 1981 after we have examined the new facts presented by President Dankert.
Det kan have været en fortalelse, det kan have været en misfortolkning, men hr. Aigner har netop foreslået Parlamentet, at hr. Såbys decharge for 1982 vil blive forelagt Parlamentet i maj.
It may have been a slip of the tongue, it may have been misinterpretation, but Mr Aigner has just proposed to the House that the Saby discharge on 1982 be delivered to the House this coming May.
Den vil nu rent faktisk ikke blive forelagt Parlamentet før april 1984.
It will not, in fact, be before the House before April 1984.
Altså decharge for 1982.
Not a discharge on 1982.
Det er vi forpligtet til, eftersom formanden har erklæret, at han har nye oplysninger, og såfremt der foreligger nye oplysninger efter budgetkontroludvalgets opfattelse, må de undersøges, selvom der er mistanke om, at overvejelser, der er sagen uvedkommende, under visse omstændigheder spiller en rolle.
We are obliged to do this because the President has stated that he has new facts at his disposal, and if in the view of the Committee on Budgetary Control new facts have emerged, then they must be examined, even if there is some suspicion that perhaps considerations which are not relevant to the matter in hand play a part here.
Budgetkontroludvalget vil sørge for, at det ikke er tilfældet.
The Committee on Budgetary Control will make sure that this is not the case.
Jeg beder Dem altså virkelig om, at De først giver hovedordføreren og så hr Tugendhat ordet.
So I earnestly request you to give the floor to the general rapporteur and then to Mr Tugendhat.
Derefter kan vi afgøre, hvad vi skal gøre.
After that we can decide what to do.
Jeg henviser til dagsordenen.
A further comment on what you said, Mr President.
Der er ikke nogen betænkning på dagsordenen om decharge til Kommissionen.
We did not defer the item on the agenda relating to the discharge just like that, and we must make a state ment on it to the Chamber pursuant to the Financial Regulation.
Hvis det ikke er på dagsordenen, kan
For the Financial Regulation lays down
Hr. Dankert havde i går bedt om en samtale med budgetkontroludvalgets formandskab.
What is on the agenda, Mr President, relates to Parliament's discharge and only that.
Det, der er på dagsordenen, hr. formand, angår Parlamentets decharge og kun det. Hr. Aigner foreslog tilbagevisning til udvalget.
President. — The situation at present is that Mr Aigner has not moved the referral back to committee.
Jeg giver nu ordet til ordføreren, hr. Schön.
I am now calling on Mr Schön, the rapporteur.